title: Polymorphisms in genes encoding tumor necrosis factor-alpha and HLA-DRB1 are not associated with response to infliximab in patients with rheumatoid arthritis.
authors.forename: José A
authors.initials: JA
authors.lastname: Pinto
authors.forename: Ignacio
authors.initials: I
authors.lastname: Rego
authors.forename: Manuel
authors.initials: M
authors.lastname: Rodríguez-Gomez
authors.forename: Juan D
authors.initials: JD
authors.lastname: Cañete
authors.forename: Carlos
authors.initials: C
authors.lastname: Fernandez-López
authors.forename: Mercedes
authors.initials: M
authors.lastname: Freire
authors.forename: Jose L
authors.initials: JL
authors.lastname: Fernandez-Sueiro
authors.forename: Raimon
authors.initials: R
authors.lastname: Sanmarti
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Blanco
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D018501:Antirheumatic Agents / Q000494:pharmacology*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000235:genetics*; D005260:Female; D006684:HLA-DR Antigens / Q000235:genetics; D059811:HLA-DRB1 Chains; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab